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Abstract 24 
 25 
The proportion of older adults in Western populations is increasing and there is, 26 
therefore, a need to define factors affecting maintenance of physical and 27 
cognitive health in old age. Variations in the Klotho (KL) gene, and specifically 28 
the KL-VS haplotype, have been identified by several authors as potentially 29 
influencing cognitive function and decline. We have attempted to verify the 30 
reported associations between KL variants, including the KL-VS haplotype, and 31 
cognitive function in up to 335,074 British Caucasian participants aged 40-79 32 
years from the UK Biobank. We do not find evidence that KL-VS affects 33 
cognitive function or its decline with increasing age. We examined a further 244 34 
KL variants and found that rs117650866 was associated with Prospective 35 
Memory, but could not replicate this in follow-up samples. In conclusion, there is 36 
insufficient evidence in the UK Biobank to support the concept that KL variants 37 
affect cognitive function or its rate of decline. 38 
39 
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Introduction 40 
 41 
The demographics of Western populations are changing, with an increase in the 42 
proportion of older adults. There is, thus, a need to define the factors affecting 43 
maintenance of physical and cognitive health in old age. Cognition can be 44 
defined as any process that is required for an individual to be aware of their 45 
situation and to use that information to respond to it (1). As individuals get older, 46 
memory, learning and processing speed decline (2); often leading to reduced 47 
independence and increased reliance on families and social care. As life 48 
expectancy increases, it becomes ever more necessary to explore some of the 49 
factors that might explain variation in cognitive function and cognitive decline in 50 
adults. 51 
 52 
Several authors have highlighted variants in the Klotho (KL) gene as associated 53 
with ageing. KL is located on chromosome 13 in humans, and encodes a single-54 
pass transmembrane protein that acts as an FGF23 co-receptor (3-5). It was 55 
first identified in mice by Kuro-o et al. (6) who showed that decreased kl 56 
expression resulted in a condition resembling premature ageing. In humans, KL 57 
variants have been reported to be associated with longevity, cardiovascular risk 58 
factors and cancer (7-10). 59 
 60 
In addition, multiple studies have been carried out exploring the relationship 61 
between KL variants and cognitive function and decline, mostly focusing on the 62 
KL-VS haplotype, which refers to a pair of functional variants that result in 63 
F352V (rs9536314) and C370S (rs9527025) substitutions. Previous evidence 64 
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has been varied: some authors have suggested that among adults aged 70 65 
years or more, people homozygous for V (valine) at position 352 have poorer 66 
cognitive function (11,12), but also suggests that V352 heterozygotes have 67 
better cognitive function than those who are homozygous for (F) phenylalanine 68 
at position 352 (11,13). On the other hand, Mengel-From et al. (14) showed 69 
that, in Danish populations aged between 92-100 years, V352 heterozygotes 70 
had poorer cognition and Almeida et al. (15) showed that among men aged 71-71 
87 years, V352 carriers were more likely to get dementia. De Vries et al. (16) 72 
showed that V352 heterozygotes have a slower rate of cognitive decline, but 73 
Porter et al. (17) did not find any such relationship in their data.  74 
 75 
In addition to the KL-VS haplotype, there are reports of associations between 76 
variants in the KL promoter region and cognition. Mengel-From et al. (14) 77 
reported that carriers of the rs398655 C allele had better cognitive function than 78 
non-carriers and Hao et al. (18) reported that those with who are homozygous 79 
for the G (guanine) allele at G-395A (rs1207568) have an increased risk of 80 
cognitive impairment. 81 
 82 
At present, conflicting reports indicate that, at a population level, the relationship 83 
between the KL-VS haplotype and cognitive function or cognitive decline is not 84 
particularly clear: there is, therefore, a need to explore this area further using 85 
significantly bigger sample sizes. Here, we aim to verify the reported 86 
associations between KL variants, including the KL-VS haplotype, and cognitive 87 
function in up to 335,074 UK Biobank (UKB) participants aged between 40 and 88 
79 years, by carrying out a phenome scan of cognitive measures, including 89 
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reaction time and various memory tests. We also aim to search for novel 90 
associations between the KL genetic variants and cognitive function using the 91 
same approach. 92 
93 
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Subjects and Methods 94 
 95 
Population and study design 96 
 97 
This study was carried out using data from the UK Biobank (UKB). UKB is a 98 
large prospective cohort study that recruited ~502,600 UK residents aged 99 
between 40 and 69 years of age between 2006 and 2010. The participants 100 
provided blood, urine and saliva samples, and underwent various physical 101 




Table 1 summarises the phenotypes relating to cognitive function (referred to as 106 
cognitive measures) that were used for our analyses. For some cognitive 107 
measures, a baseline measurement was carried out (referred to as ‘Baseline’) 108 
at one of 22 assessment centres as well as 2 follow-up measurements (referred 109 
to as ‘Follow-Up 1’ and ‘Follow-Up 2’) for a subset of participants. For Fluid 110 
Intelligence, Pairs Matching and Numeric Memory, an online assessment was 111 
performed in addition to the measurements undertaken at the assessment 112 
centres. For Pairs Matching, there were 3 rounds; the first round had 3 pairs 113 
that the participants needed to match and the second and third rounds had 6. 114 
For Trail Making, only data from the online measurement was available to us. 115 
We did not include participants in the analysis for a given cognitive function test 116 
if they abandoned the test and/or if they completed the test with a pause. Each 117 
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round/follow-up of each measure was treated as a separate phenotype unless 118 
otherwise stated. 119 
 120 
Genotyping and quality control 121 
 122 
488,377 individuals were genotyped for up to 812,428 variants using DNA 123 
extracted from blood samples on either the UK Biobank Axiom array (438,427 124 
participants) and the UK BiLEVE Axiom array (49,950 participants). Variant 125 
quality control metrics were provided by UKB as described previously (20). For 126 
genotyped variants, all variants that did not pass standard quality control checks 127 
carried out by Affymetrix and the Wellcome Trust Centre for Human Genetics 128 
were excluded. Specifically, hypothesis testing was carried out to check for 129 
differences in genotyping due to batch effects, plate effects, sex effects and 130 
array effects as well as any departures from Hardy-Weinberg Equilibrium using 131 
a p-value threshold of 10-12. In addition, variants with a missingness of >1% 132 
and/or a minor allele frequency of <0.01 were also excluded. For imputed 133 
variants, all variants with an INFO score of <0.8 were excluded. The KL gene is 134 
located at 13:33590571-33640282 (GRCh37.p13) and 246 variants passed QC 135 
within ±5 Kb of KL. These were selected for the association analyses. 136 
 137 
Sample quality control metrics were provided by UKB and were generated as 138 
described by Bycroft et al. (20). Samples were excluded from the analysis if 139 
they were determined to be outliers for missingness and/or heterozygosity 140 
and/or if they had any sex chromosome aneuploidies as well as if the 141 
genetically inferred sex differed from the reported sex. Samples which did not 142 
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have a genetically-determined White British ancestry were also excluded. A list 143 
of related individuals was also provided by UK Biobank and one individual from 144 
each related pair was excluded at random. 145 
 146 
Statistical Analyses 147 
 148 
PLINK 2.0 was used to fit an additive linear model between the cognitive 149 
measures and the genotypes in all individuals. This was then repeated for a 150 
subset of individuals who were aged 69 years or more at the time of performing 151 
the cognitive test. Unless otherwise specified, all association analyses (i.e. 152 
additive linear models) were adjusted for the first 4 genetic principal 153 
components (PCs) (UKB Field 22009) and the genotyping chip on which the 154 
participant was genotyped on. The cognitive measures and any quantitative 155 
covariates were standardised to a mean of 0 and a variance of 1 before any 156 
linear modelling was performed.  157 
 158 
Since multiple testing was undertaken, we applied statistical correction for this. 159 
A principal component (PC) analysis showed that 24 PCs represented >90% of 160 
variation in the 28 cognitive measures. To determine the number of 161 
independent variants, all pairs of variants within the locus with R2 > 0.1 were 162 
listed, one variant from each pair was removed and this process was repeated 163 
until there were no pairs of variants remaining. When this is implemented using 164 
--indep-pairwise 60 kb 1 0.1 in PLINK 2.0, 15 independent variants remain. A p-165 
value threshold of 0.05 is used and Bonferroni-corrected when necessary for 166 
the appropriate number of independent tests in each case (up to 360 167 
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independent tests: 15 independent variants and 24 PCs). Supplementary Figure 168 
1 summarises the analyses and the threshold used for each of them. 169 
170 
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Results 171 
 172 
After QC, there were 335,074 individuals remaining for analysis. A summary of 173 
the sample by phenotype is provided in Table 2. 174 
 175 
Since the 2 variants making up the KL-VS haplotype are well-characterised 176 
functional KL variants in humans, we investigated whether either of them was 177 
associated with any of the cognitive function measures available. Neither 178 
rs9536314 nor rs9527025 were significantly associated at a p-value threshold of 179 
0.05/24 with any of the cognitive measures when unadjusted (Supplementary 180 
Table 1) and when adjusted for age, age2 and sex (Figure 1). 181 
 182 
Previous studies have largely concentrated on older individuals: to test whether 183 
these variants exerted their effects only in later life, we repeated the analyses, 184 
but only included individuals who were aged ≥69 years at the time that they 185 
performed the cognitive test. However, we again found that neither rs9536314 186 
nor rs9527025 were significantly associated at a p-value threshold of 0.05/24 187 
with any of the cognitive measures available (Figure 1 & Supplementary Table 188 
1). It was not possible to increase this age threshold beyond 69 years because 189 
all participants were aged between 40 and 69 years at the time of recruitment. 190 
 191 
Although the associations were not statistically significant, the effect size 192 
appeared to increase when excluding individuals under the age of 69 years. We 193 
therefore repeated the analyses but included a genotype*age interaction term to 194 
test whether the effect of KL-VS variants on the cognitive function measures 195 
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available changed with age. We found that age does not have a statistically 196 
significant effect on the relationship between KL-VS and any of the cognitive 197 
function measures available at a p-value threshold of 0.05/24 adjusting for age, 198 
age2 and sex (Supplementary Table 2). 199 
 200 
We next sought to test whether rs9536314 or rs9527025 were associated with 201 
change in any of the cognitive measures over age. For all measures for which 202 
more than one data point was available per participant (i.e. participants had 203 
performed a given cognitive test on more than one occasion), a rate of change 204 
was calculated for each participant (where the rate of change is the change in 205 
the cognitive measure, M2-M1, divided by the age difference, T2-T1, in years: 206 
on average, the difference between two measurements is 8.3 years). We found 207 
that neither rs9536314 nor rs9527025 was significantly associated at a p-value 208 
threshold of 0.05 with a change in any of the available cognitive measures over 209 
age, either when unadjusted or when adjusted for ageT1, ageT1
2 and sex 210 
(Supplementary Table 3). 211 
 212 
We next tested to see if any other KL variants were statistically associated at a 213 
p-value threshold of 0.05/360 with any of the available cognitive measures. We 214 
found that rs117650866 was associated with Prospective Memory (UKB Field 215 
4291) adjusting for age, age2 and sex (referred to as Discovery in Table 3). 216 
There were no other significant associations, with or without adjustment for age, 217 
age2 and sex (Supplementary Table 4 & 5); there were also no significant 218 
associations when excluding individuals under the age of 69 years 219 
(Supplementary Table 4 & 5). 220 
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 221 
We then attempted to internally replicate the rs117650866 association. To do 222 
this, we repeated the association analysis in participants who performed the 223 
Prospective Memory test only on one occasion (i.e. those participants who 224 
performed the test at either Baseline only, or at Follow Up 1 only, or at Follow 225 
Up 2 only). The rs117650866 association was present in those tested at 226 
Baseline only (beta = 0.112, s.e. = 0.0229, power = 0.92, v = 99054), but was 227 
absent (p > 0.05) in those tested only at either Follow Up 1 only (beta = -0.059, 228 
s.e. = 0.0794, power = 0.12, v = 8179) or at Follow Up 2 only (beta = -0.117, 229 
s.e. = 0.101, power = 0.09, v = 5656) (Table 3). Despite the lack of power to 230 
detect the association observed at Baseline, the inconsistent direction of the 231 
effect between Baseline and Follow Up 1 and 2 suggest that the association 232 
observed at Baseline was likely to be a false positive. The power calculations 233 
were carried out using the pwr.f2.test function from the pwr package in R with u 234 
set to 9, f2 set to 0.000216 and sig.level set to 0.05. 235 
 236 
We next sought to test whether any KL variants were significantly associated at 237 
a p-value threshold of 0.05/15 with a change in any of the cognitive measures 238 
(for which there are repeat measurements) over age, in the same way that KL-239 
VS was tested. We did not find any significant associations (Supplementary 240 
Table 6). 241 
242 
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Discussion 243 
 244 
Previous evidence suggested that KL-VS and other KL variants are associated 245 
with cognitive function during the later stages of life. Our aim was to explore 246 
these findings in a younger and much larger cohort, namely the UK Biobank. 247 
We did not find evidence of a relationship between KL-VS and cognitive 248 
function, nor did we find any evidence that the age of an individual had a 249 
significant effect on this relationship. The association we found between 250 
Prospective Memory and rs117650866 did not replicate consistently, nor is 251 
there any evidence of it in previously published studies, so it is likely to be a 252 
false positive. We also did not find evidence of any other KL variants being 253 
associated with cognitive function nor with cognitive decline. 254 
 255 
An important point is that previous studies which have identified relationships 256 
between KL variants and cognition use populations that are much older (usually 257 
aged 70 years or more), whereas the population we examined is relatively 258 
young (the larger Baseline samples had a mean age of 57 years). We 259 
attempted to address this limitation by repeating our analyses, but only 260 
including individuals over the age of 69 years; we still did not find associations 261 
probably because only about 1% of this subset in the Online tests are over 75 262 
years of age and no individuals are over 79 years of age. Indeed, whenever 263 
authors report an absence of statistically significant associations between KL 264 
variants and cognition, the mean age of the cohorts that they analyse are closer 265 
to the one we analysed. For example, Deary et al. (12) examined 2 cohorts and 266 
the cohort who undertook cognitive testing at age of 64 years did not show 267 
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statistically significant associations between KL-VS and cognition. Dubal et al. 268 
(13) also did not find an association in one of the 3 cohorts that they analysed, 269 
and the mean age of this cohort was 63 years. 270 
 271 
Deary et al. (12) provided evidence suggesting that KL-VS may influence 272 
cognitive decline. We did not find any evidence to support this. This may be 273 
because the difference between the repeated measurements available to us 274 
was about 8 years whereas Deary et al. compared the cognitive abilities of 275 
individuals first tested when aged 11 years and then at the age of 79 years. It is 276 
also important to note that whilst some authors do report relationships between 277 
KL-VS and cognitive decline (12,16), other authors do not find any such 278 
relationship (14,17). 279 
 280 
The UKB dataset, despite the advantage of its size, does have biases. In 281 
particular, the participants are generally healthier than average (21). There is 282 
evidence to suggest that the effect of KL variants on cognitive function/decline 283 
may be as a result of affecting the severity of a pre-existing psychopathology 284 
(22,23) and individuals suffering from early dementia, etc. would be either 285 
unlikely or even unable to volunteer to participate. 286 
 287 
In conclusion, there is insufficient evidence in the UK Biobank to support the 288 
concept that KL variants affect cognitive function or its rate of decline in British 289 
Caucasian individuals aged between 40 and 79 years. Further follow-up testing 290 
would be required to verify the reported effects of KL on cognitive function and 291 
decline that are reported in very elderly individuals. 292 
293 
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Figures 385 
 386 
Figure 1 387 
Standardised beta coefficients with 95% Confidence Intervals when regressing 388 
cognitive measures on rs9536314 and on rs9527025 in the UK Biobank with (All 389 
Participants) and without (≥69) including participants less than 69 years old and 390 
adjusted for age, age2 and sex. 391 
 392 
Supplementary Figure 1 393 
A breakdown of the analyses carried out in this study. LD = linkage 394 
disequilibrium. PCs = principal components.  395 
396 
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (which wasthis version posted November 19, 2019. ; https://doi.org/10.1101/838409doi: bioRxiv preprint 
Tables 397 
 398 
Table 1 399 
A description of the cognitive measures from the UK Biobank used in this study. 400 
 401 
Table 2 402 
Demographics of the cohort by phenotype. The distribution of the phenotype is 403 
presented in the original units. 404 
 405 
Table 3 406 
Standardised coefficients (beta), standard errors (s.e.), sample sizes (n) and p-407 
values (p) when regressing cognitive measures on rs117650866 in the UK 408 
Biobank adjusted for age, age2 and sex in the full baseline sample (Discovery), 409 
and in 3 independent samples (i.e. in participants who were present at baseline 410 
only (Baseline) and in participants who were present at the first follow up only 411 
(Follow Up 1) and in participants who were present at the second follow up only 412 
(Follow Up 2)).  413 
 414 
Supplementary Table 1 415 
Standardised coefficients (beta), standard errors (s.e.), sample sizes (n) and p-416 
values (p) when regressing cognitive measures on rs9536314 and on 417 
rs9527025 in the UK Biobank with (All Participants) and without (≥69 years old) 418 
including participants less than 69 years old and not adjusted. 419 
 420 
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Standardised coefficients (beta), standard errors (s.e.), sample sizes (n) and p-422 
values (p) when regressing cognitive measures on rs9536314 and on 423 
rs9527025 in the UK Biobank with a genotype*age interaction term and 424 
adjusted for age, age2 and sex. 425 
 426 
Supplementary Table 3 427 
Standardised coefficients (beta), standard errors (s.e.), sample sizes (n) and p-428 
values (p) when regressing the rate of decline of cognitive measures on 429 
rs9536314 and on rs9527025 in the UK Biobank with (Adjusted) and without 430 
(Unadjusted) adjusting for ageT1, ageT1
2 and sex. 431 
   432 
Supplementary Table 4 433 
Standardised coefficients (beta), standard errors (s.e.), sample sizes (n) and p-434 
values (p) when regressing cognitive measures on 246 KL variants in the UK 435 
Biobank with (All Participants) and without (≥69 years old) including participants 436 
less than 69 years old and not adjusted. 437 
 438 
Supplementary Table 5 439 
Standardised coefficients (beta), standard errors (s.e.), sample sizes (n) and p-440 
values (p) when regressing cognitive measures on 246 KL variants in the UK 441 
Biobank with (All Participants) and without (≥69 years old) including participants 442 
less than 69 years old and adjusted for age, age2 and sex. 443 
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Standardised coefficients (beta), standard errors (s.e.), sample sizes (n) and p-446 
values (p) when regressing the rate of decline of cognitive measures on 246 KL 447 
in the UK Biobank with (Adjusted) and without (Unadjusted) adjusting for ageT1, 448 
ageT12 and sex. 449 
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